Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of norfloxacin in rats

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 6, 2003, Pages 1952-1957

  Chenel, Marylore ^a   Barbot, Agnès ^a,b   Dupuis, Antoine ^a,b   Mimoz, Olivier ^a,b   Paquereau, Joël ^a   Bouquet, Serge ^a,b   Couet, William ^a  

^a PBS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; CONCENTRATION RESPONSE; CURVE FITTING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; ELECTROENCEPHALOGRAPHY; EPILEPSY; MALE; MODEL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; ELECTROENCEPHALOGRAPHY; INFUSIONS, INTRAVENOUS; MALE; MODELS, BIOLOGICAL; NORFLOXACIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037764101     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.6.1952-1957.2003     Document Type: Article

References (20)

1. Akaike, A. 1978. Probabilities for choosing a regression model. Ann. Inst. Math. Stat. 30:A9-A14.
2. Bouw, M. R., R. Xie, K. Tunblad, and M. Hammarlund-Udenaes. 2001. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats. Pharmacokinetic/pharmacodynamic modelling. Br. J. Pharmacol. 134:1796-1804.
3. Christ, W. 1990. Central nervous system toxicity of quinolones: human and animal findings. J. Antimicrob. Chemother. 26(Suppl. B):219-225.
4. Davis, J. D., L. Aarons, and J. B. Houston. 1995. Effect of norfloxacin on theophylline disposition: a comparison with other fluoroquinolones. Pharm. Res. 12:257-262.
5. Della Paschoa, O. E., J. W. Mandema, R. A. Voskuyl, and M. Danhof. 1998. Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats. J. Pharmacol. Exp. Ther. 284:460-466.
6. Delon, A., S. Bouquet, F. Huguet, V. Brunet, P. Courtois, and W. Couet. 1999. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats. Antimicrob. Agents Chemother. 43:1511-1515.
7. Delon, A., F. Huguet, P. Courtois, J. M. Vierfond, S. Bouquet, and W. Couet. 1997. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and NOR in rats. J. Pharmacol. Exp. Ther. 280:983-987.
8. Delon, A., L. M. Levasseur, M. Giraudon, S. Bouquet, and W. Couet. 1999. Antagonistic interaction between the convulsant activities of pefloxacin and its main metabolite NOR in rats. Pharm. Res. 16:1894-1897.
9. Dupuis, A., W. Couet, J. Paquereau, S. Debarre, A. Portron, C. Jamois, and S. Bouquet. 2001. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats. Antimicrob. Agents Chemother. 45:1682-1687.
10. Dupuis, A., C. Pariat, P. Courtois, W. Couet, and S. Bouquet. 2000. Imipenem but not meropenem induces convulsions in DBA/2 mice, unrelated to cerebrospinal fluid concentrations. Fundam. Clin. Pharmacol. 14:163-165.
11. Fuseau, E., and L. B. Sheiner. 1984. Simultaneous modelling of pharmacokinetics and pharmacodynamics with a non parametric pharmacodynamic model. Clin. Pharmacol. Ther. 35:733-741.
12. Hammarlund-Udenaes, M., K. K. Paalzow, and E. C. M. de Lange. 1996. Drug equilibration across the blood-brain barrier-pharmacokinetic considerations based on the microdialysis method. Pharm. Res. 14:128-134.
13. Jusko, W. J., and H. C. Ko. 1994. Physiologic indirect response models characterize diverse types of pharmacodynamic effects. Clin. Pharmacol. Ther. 56:406-419.
14. Niedermeyer, E., and F. Lopez da Silva. 1998. Electroencephalography: basic principles, clinical applications and related fields, 4th ed., p. 1135-1163. Lippincot, Williams and Wilkins, Baltimore, Md.
15. Schwarz, G. 1978. Estimating the dimension of a model. Ann. Stat. 6:461-464.
16. Sheiner, L. B., D. R. Stanski, S. Vozeh, R. D. Miller, and J. Ham. 1979. Simultaneous modelling of pharmacokinetics and pharmacodynamics: application of d-tubocurarine. Clin. Pharmacol. Ther. 25:358-371.
17. Snedecor, G. W., and W. G. Cochran. 1989. Statistical methods, 8th ed. Iowa State University Press, Ames, Iowa.
18. Wallace, K. L. 1997. Antibiotic-induced convulsions. Crit. Care Clin. 13:741-762.
19. Welty, D. F., G. G. Schielke, M. G. Vartanian, and C. P. Taylor. 1993. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Res. 16:175-181.
20. Zar, J. H. 1996. Biostatistical analysis, 3rd ed. Prentice Hall, Upper Saddle River, N.J.